Physician profile
Ivan Lee
NPI 1942769831
$2,459.53
in general payments reported to CMS, 2019-2025
12 companies · $590 in 2025
The $590 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $99.99 · 2022: $196 · 2023: $1,574 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,361 · Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,361.27 |
| Food and Beverage | $802.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,632.33 | 2023-2025 | Clareon, Constellation |
| Apellis Pharmaceuticals, INC. | $163.07 | 2025 | Syfovre |
| Genentech USA, INC. | $158.44 | 2022-2025 | Vabysmo |
| Allergan, INC. | $99.99 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $92.81 | 2025 | Eylea Hd |
| Glaukos Corporation | $71.33 | 2022 | |
| Abbvie INC. | $62.97 | 2025 | |
| Ocular Therapeutix, INC. | $57.46 | 2025 | Dextenza |
| Ani Pharmaceuticals, INC. | $41.31 | 2025 | Iluvien |
| Regeneron Pharmaceuticals, INC. | $33.86 | 2025 | Eylea Hd, Eylea |
| Astellas Pharma US INC | $23.81 | 2025 | Izervay |
| Bausch & Lomb Americas INC. | $22.15 | 2025 | Xipere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.